Your Premier Destination for High-Quality Aesthetic Products and Transformative Beauty Solutions
Return to previous page
What Is PDRN? Salmon DNA Skin Rejuvenation Explained
What Is PDRN? How Salmon DNA Fragments Regenerate Skin From the Receptor Level
Written by FillersFairy Editorial · Reviewed by FillersFairy Clinical Team · Last updated: June 30, 2026
Quick Answer
PDRN (polydeoxyribonucleotide) is a DNA-derived biopolymer extracted from salmon sperm cells, consisting of DNA fragments in the 50–1,500 kDa molecular weight range. It works by selectively activating adenosine A2A receptors on fibroblasts, triggering a cascade that stimulates collagen synthesis, reduces inflammation (via NF-κB suppression), and promotes angiogenesis (via VEGF upregulation). Originally developed for wound healing, PDRN has been adopted in aesthetics for intensive skin rejuvenation, texture improvement and anti-ageing. Products like Curenex Glow combine PDRN with peptides, glutathione and HA for multi-target regeneration. PDRN represents the “targeted repair” tier in the regenerative treatment ladder — more precise than HA, more direct than PN.
What PDRN Actually Is
PDRN stands for polydeoxyribonucleotide — a class of DNA fragments derived from salmon or trout sperm cells. The term describes the molecular composition precisely: poly (many) + deoxy (deoxyribose sugar) + ribo (ribose backbone) + nucleotide (the building blocks of DNA).
What makes PDRN specific — and what distinguishes it from broader “polynucleotide” (PN) preparations — is its molecular weight range: 50 to 1,500 kDa. This range is not arbitrary. Published research confirms that DNA-derived molecules within this specific weight range selectively bind to adenosine A2A receptors, while molecules outside this range do not bind to the same receptor with the same affinity.
PDRN’s pharmaceutical history begins in wound healing. The product Placentex (originally derived from human placenta, later from salmon) was used in Italy for decades to accelerate healing of burns, ulcers and surgical wounds. Its transition into aesthetics happened when practitioners observed that the same tissue repair mechanisms that healed wounds also improved skin quality — texture, elasticity, luminosity and firmness.
How PDRN Works — The A2A Receptor Pathway
PDRN’s therapeutic effects are mediated through two primary pathways:
1. A2A Adenosine Receptor Activation
When PDRN fragments bind to A2A adenosine receptors on fibroblasts, a signalling cascade begins: A2A activation → increased intracellular cAMP → protein kinase A (PKA) activation → downstream effects on cell growth, survival and repair. This has been confirmed experimentally — the A2A receptor antagonist ZM241385 blocks PDRN’s effects, proving the receptor-mediated mechanism.
The downstream effects of A2A activation include:
| Downstream Effect | Mechanism | Clinical Result |
|---|---|---|
| Collagen synthesis | MMP-1 downregulation → collagen degradation slows; fibroblast proliferation → new collagen production increases | Firmer, more elastic skin with reduced fine lines |
| Anti-inflammation | NF-κB and MAPK cascade suppression → reduced pro-inflammatory cytokines (TNF-α, IL-6) | Calmer skin, faster post-procedure recovery, reduced redness |
| Angiogenesis | HIF-1α induction → VEGF upregulation → endothelial cell proliferation | Improved microcirculation, better nutrient delivery to skin, healthier complexion |
| DNA repair | Purine and pyrimidine nucleotides enter the salvage pathway → support cellular DNA repair and synthesis | Accelerated cellular regeneration, UV damage recovery |
2. Nucleotide Salvage Pathway
Beyond receptor activation, PDRN provides raw materials — purine and pyrimidine bases — that cells use to repair their own DNA. This is especially valuable in damaged or aged skin where the cells’ natural DNA repair capacity has declined. PDRN essentially supplies the building blocks that cells need but can no longer produce efficiently.
What PDRN Does to Skin
In vitro studies show PDRN promotes human dermal fibroblast proliferation by approximately 25% compared to controls. Plant-derived PDRN promotes keratinocyte growth and accelerates wound closure in 3D skin models. Clinical observations align with the in vitro data:
| Skin Concern | What PDRN Does | Timeline |
|---|---|---|
| Fine lines and wrinkles | Stimulates collagen synthesis via MMP-1 suppression + fibroblast activation | Week 2–4 |
| Dull complexion | Improves microcirculation via VEGF-mediated angiogenesis | Week 1–2 |
| Post-procedure recovery | Reduces inflammation via NF-κB suppression + accelerates tissue repair | Days 1–7 |
| Loss of elasticity | Increases fibroblast activity → collagen + elastin production | Week 3–6 |
| UV-damaged skin | Supplies nucleotides for DNA repair via salvage pathway + SIRT1 upregulation | Cumulative |
PDRN vs PN — The Key Difference
Both PDRN and PN come from salmon DNA. Both activate A2A receptors. So what’s different?
| Feature | PDRN | PN |
|---|---|---|
| Full name | Polydeoxyribonucleotide | Polynucleotide |
| Molecular weight | 50–1,500 kDa (smaller) | Broader range, larger molecules |
| Primary mechanism | Direct A2A receptor activation + DNA repair | A2A activation + structural scaffold support |
| Action style | Targeted, intensive repair | Broader, sustained rejuvenation |
| Clinical strength | Faster regeneration, strong anti-inflammatory | Longer-lasting structural support, robust collagen |
| Representative product | Curenex Glow | Rejuran |
Think of it this way: PN provides the building blocks and structural framework for skin repair — like the bricks and mortar. PDRN sends the direct repair signal to the cells — like the construction order. Both are valuable. Many clinics stock both, using PDRN for intensive targeted repair and PN for broader maintenance rejuvenation. For a detailed comparison, see our PN vs PDRN comparison guide.
PDRN Products for Aesthetic Practice
The most widely used PDRN product in the Korean aesthetic market is Curenex Glow — which goes beyond pure PDRN by combining it with 15 peptides, glutathione, hyaluronic acid and collagen in a single 5 mL vial. This multi-ingredient approach addresses skin quality from multiple angles simultaneously, making it the premium tier in the PDRN category.
For clinics building their regenerative treatment menu, PDRN products serve as the “intensive repair” option — positioned above HA boosters (hydration) and alongside PN therapy (structural support). Check Curenex Glow wholesale pricing →
Clinical Applications
Standalone skin rejuvenation: 3–4 sessions at 2–4 week intervals for texture, elasticity and luminosity improvement.
Post-procedure recovery: Applied after laser, microneedling or chemical peels to accelerate healing and reduce downtime via NF-κB-mediated anti-inflammatory action.
Combination protocols: PDRN + HA mesotherapy (Hyaron for hydration + Curenex Glow for regeneration). PDRN + exosome therapy (ASCE+ SRLV for multi-target cell signalling + PDRN for targeted receptor activation).
Ageing skin maintenance: Monthly PDRN sessions for patients over 40 whose natural DNA repair capacity and fibroblast activity have declined.
How to Position PDRN in Your Clinic
PDRN fits between HA boosters and exosome therapy on the regenerative treatment ladder:
HA Skin Boosters (Hyaron) → Hydration → Entry-level → Wholesale pricing →
PN Therapy (Rejuran) → Collagen stimulation → Regenerative → Wholesale pricing →
PDRN (Curenex Glow) → Intensive targeted repair → Premium regenerative → Wholesale pricing →
Exosomes (ASCE+ SRLV) → Multi-target cell signalling → Most advanced → Wholesale pricing →
Each step up commands higher per-session pricing. Patients who start with HA progress naturally to PN, then PDRN, then exosomes — each upgrade increasing per-visit revenue.
Practitioner Confidence Summary
PDRN is not marketing — it’s pharmacology. The A2A receptor mechanism is well-documented across 29+ published studies spanning skin, bone and cartilage regeneration. In vitro data shows 25% fibroblast proliferation increase. Clinical data confirms improvements in collagen, elasticity, inflammation and wound healing. For aesthetic practitioners, PDRN represents the targeted repair tier of regenerative treatment — more precise than HA, more direct than PN. Products like Curenex Glow combine PDRN with complementary actives for a comprehensive single-product protocol. View Curenex Glow product details →
Frequently Asked Questions
What is PDRN made from?
PDRN is extracted from salmon or trout sperm cells (Oncorhynchus mykiss or Oncorhynchus keta). The extraction process produces DNA fragments in the 50–1,500 kDa molecular weight range. This specific weight range is what enables A2A adenosine receptor binding.
How does PDRN work on skin?
PDRN binds to A2A adenosine receptors on fibroblasts, triggering a signalling cascade (cAMP → PKA) that stimulates collagen production, reduces inflammation (NF-κB suppression), promotes blood vessel growth (VEGF upregulation), and supplies DNA repair building blocks via the salvage pathway.
What is the difference between PDRN and PN?
Both come from salmon DNA and both activate A2A receptors. PDRN has smaller molecules (50–1,500 kDa) and acts more directly on receptor-mediated repair. PN has larger molecules providing broader structural support and longer-lasting tissue scaffolding. PDRN is more targeted; PN is more sustained. Many clinics use both.
Which product contains PDRN?
Curenex Glow is the most widely used PDRN product in Korean aesthetics — combining PDRN with 15 peptides, glutathione, HA and collagen in a 5 mL vial. Hyalmass Aqua Exosome also contains 0.01% PDRN alongside HA and exosomes in a pre-mixed syringe format.
How many PDRN sessions do I need?
Standard aesthetic protocol is 3–4 sessions at 2–4 week intervals, followed by monthly maintenance. Results are gradual — improved luminosity from Week 1–2, texture improvement from Week 2–4, cumulative collagen building over the full course.
Related Guides
Disclosure: FillersFairy is a wholesale supplier of PDRN products. This article is for educational purposes only and does not constitute medical advice.
References
- Kim J, et al. “Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives.” PMC12388916. 2025.
- Guizzardi S, et al. “Polydeoxyribonucleotides From Skin to Musculoskeletal Tissue Regeneration via Adenosine A2A Receptor Involvement.” J Cell Physiol. 2017.
- JCAS. “Polynucleotides and polydeoxyribonucleotides in dermatology — A narrative review.” jcasonline.com. 2026.
- Shin J, et al. “Polydeoxyribonucleotides as Emerging Therapeutics for Skin Diseases.” Appl Sci. 2025;15(19):10437.
